Debate is needed over who provides drug treatment in attention deficit hyperactivity disorderBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7132.704 (Published 28 February 1998) Cite this as: BMJ 1998;316:704
- Kapil Sayal, Clinical research worker
- Institute of Psychiatry, London SE5 8AF
EDITOR—Levy's editorial on attention deficit hyperactivity disorder focuses on treatment issues in Australia and the United States, which only partially generalise to the current situation in Britain.1 Although the diagnostic criteria given in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders for attention deficit hyperactivity disorder and in the 10th revision of the International Statistical Classification of Diseases and Related Health Problems for hyperkinetic disorder are much more comparable than their predecessors …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial